Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP)
Evaluating the impact of communicating high polygenic risk for coronary artery disease on the health behaviour of young overweight adults: a pragmatic randomised controlled trial
Stroke Action Plan for Europe 2018-2030 (SAP-E): mid-term review and update.
Preliminary results of the evaluation of pharmacokinetic profiles in Haemophilia A patients receiving Efanesoctocog Alfa
Consistency and Within-Subject Variation in the Interpretation of von Willebrand Factor Multimers Using Semi-Automated Hydragel Assay
Performance Evaluation of a One-Stage Clotting Assay in Monitoring Efanesoctocog Alfa Activity: Insights from the ECAT 2024 Survey
Pragmatic trial assessing polygenic risk driven statin therapy for cardiovascular disease prevention: study protocol for the EE-PRS trial
Global survey of genetic testing methods for familial hypercholesterolemia. A study and recommendations from the EAS FHSC registry.
Hypertension in autoimmune rheumatic diseases – a position paper from the ESH working group on small arteries.
Hypertension in autoimmune rheumatic diseases: a position paper from the European Society of Hypertension working group on small arteries. Part A: pathophysiology, prevalence and cardiovascular risk estimation.
Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics.
Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV Trial.
Laboratoorsed võimalused otseste suukaudsete antikoagulantide toime hindamiseks
Meta-analysis of smartphone applications targeting eating behaviour for weight loss